Zolodrenic acid can prevent early bone loss in HIV patients on antiretroviral therapy
A single dose of the drug zoledronic acid was found to inhibit the bone loss that is common in HIV-infected patients and that is increased during the first two years of treatment with antiretroviral therapy (ART). Bone loss ...
Feb 23, 2016
0
4